Texas Medical Algorithm Project

Pliszka SR, Greenhill LL, Crismon ML, et al. The Texas medication algorithm project Report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder, parts 1 and 2. J Am Acad Child Adolesc Psychiatry 2000 39 908-927. 

Miller AL, Hall CS, Buchanan RW, et al. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia 2003 Update. J Clin Psychiatry 2004 65 500-508. 

Rush AJ, Crismon ML, Toprac MG, et al. Implementing guidelines and systems of care Experiences with the Texas Medication Algorithm Project (TMAP). J Pract Psychiatry Behav Health 1999 5 75-86. 

Bilder RM, Goldman RS, Volavka J, et al. Neurocognitive effects of clozapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002 159 1018-1028. Miller AL, Crismon ML, Rush AJ, et al. The Texas Medication Algorithm Project clinical results for schizophrenia. Schizophr Bull (in press). Pisani F, Oteri G, Costa C, et al. Effects of psychotropic drugs on seizure threshold. Drug Saf 2002 25 91-110. 

Suppes T, Rush AJ, Dennehy EB, et al. Texas Medication Algorithm Project, phase 3 (TMAP-3) Clinical results for patients with a history of mania. J Clin Psychiatry 2003 64 370-382. 

Texas Children s Medication Algorithm Project Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-deficit/hyperactivity disorder. Part I. Attention-deficit/hyperactivity disorder. / Am Acad Child Adolesc Psychiatry 39 908—919. 

Pliszka, S.R., Greenhill, L.L., Crismon, M.L., Sedillo, A., Carlson, C., Conners, C.K., McCracken, J.T., Swanson, J.M., Hughes, C.W, Liana, M.E., Lopez, M., and Toprac, M.G. (2000b) The Texas Children s Medication Algorithm Project Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II Tactics. Attention-deficit/hyperactivity disorder. / Am Acad Child Adolesc Psychiatry 39 920—927. 

---